Volume 24 - Issue 10 - October 2016
News
News
10/31/2016
It is an exciting time in the development of therapies to treat atopic dermatitis.
It is an exciting time in the development of therapies to treat atopic dermatitis.
It is an exciting time in the...
10/31/2016
The Dermatologist
News
10/31/2016
The National Rosacea Society (NRS) has awarded funding for 3 new studies, in addition to continuing support for 2 ongoing studies, as part of its research grants program to increase knowledge and understanding of the causes and other key...
The National Rosacea Society (NRS) has awarded funding for 3 new studies, in addition to continuing support for 2 ongoing studies, as part of its research grants program to increase knowledge and understanding of the causes and other key...
The National Rosacea Society...
10/31/2016
The Dermatologist
Department
Research in Review
10/31/2016
Atopic dermatitis is a common skin disease that is burdensome for affected individuals. Repairing the skin barrier or preventing barrier dysfunction is the cornerstone of atopic dermatitis management.
Atopic dermatitis is a common skin disease that is burdensome for affected individuals. Repairing the skin barrier or preventing barrier dysfunction is the cornerstone of atopic dermatitis management.
Atopic dermatitis is a common...
10/31/2016
The Dermatologist
Derm Dx
10/28/2016
A 71-year-old Caucasian man presented with a lesion on his right flank that had been present for 3 months.
A 71-year-old Caucasian man presented with a lesion on his right flank that had been present for 3 months.
A 71-year-old Caucasian man...
10/28/2016
The Dermatologist
The Dermatopathologist
10/28/2016
In this case, a rare form of tumefactive fibrosing vasculitis presents as an orbital pseudotumor.
In this case, a rare form of tumefactive fibrosing vasculitis presents as an orbital pseudotumor.
In this case, a rare form of...
10/28/2016
The Dermatologist
Board Review
10/28/2016
The contents of these questions are taken from the Galderma Pre-Board Webinar.
The contents of these questions are taken from the Galderma Pre-Board Webinar.
The contents of these questions...
10/28/2016
The Dermatologist
Research in Review
10/19/2016
Learn how FDA decides a biosimilar is safe and effective and what NPF is doing to make sure doctors get to decide when a biosimilar is the best option.
Learn how FDA decides a biosimilar is safe and effective and what NPF is doing to make sure doctors get to decide when a biosimilar is the best option.
Learn how FDA decides a...
10/19/2016
The Dermatologist
10/28/2016
The American Academy of Dermatology (AAD) is accepting applications for its AAD Cochrane Scholarship, which promotes training in evidence-based medicine in dermatology.
The American Academy of Dermatology (AAD) is accepting applications for its AAD Cochrane Scholarship, which promotes training in evidence-based medicine in dermatology.
The American Academy of...
10/28/2016
The Dermatologist
Column
Spotlight
10/28/2016
Iltefat Hamzavi , MD, is a metro Detroit-based dermatologist.
Iltefat Hamzavi , MD, is a metro Detroit-based dermatologist.
Iltefat Hamzavi , MD, is a metro...
10/28/2016
The Dermatologist
Chief Medical Editor Message
10/28/2016
We should actively think about what we don’t see when drawing conclusions from such observations.
We should actively think about what we don’t see when drawing conclusions from such observations.
We should actively think about...
10/28/2016
The Dermatologist
